Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies
about
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectRationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectMedical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphomaInfluence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.Parity, Age at First Birth, and Risk of Death from Non-Hodgkin's Lymphoma: A Population-Based Cohort Study in TaiwanNew insights into the epidemiology of non-Hodgkin lymphoma and implications for therapyHormonal and Reproductive Factors and Risk of Myeloproliferative Neoplasms in Postmenopausal Women.Inhibition of estrogen biosynthesis enhances lymphoma growth in mice.To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes.The emerging role of estrogen in B cell malignancies.Menopausal estrogen therapy and non-Hodgkin's lymphoma: A post-hoc analysis of women's health initiative randomized clinical trial.Dissecting lymphoma incidence to inform epidemiologic and clinical research.The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma.
P2860
Q28393769-9DFD7E26-3A0F-41B9-B417-C27FDF54BFAEQ34137915-DCB2D862-7233-402E-B6F7-2A1DF930307FQ34137923-DF6BC5FE-F27D-4A0F-B061-4E17BD521567Q34137948-C879F198-2A46-4019-82FC-4C554546E1A1Q34999235-8B61628E-ECB0-4080-8D79-20D962210349Q35092570-432D4E6F-64E1-4BA7-A834-7651BD42A857Q36012827-A3390A56-6C6C-4568-8F0A-A5DDFC5F8711Q36424072-455D237D-8048-4551-B80A-91D0B8B8F029Q36463786-B79A0C3F-4676-4EC3-910D-65F238A45FD5Q37190419-79569169-6FCA-4311-81A7-85C33A4AD667Q38536210-FE6360DF-359A-43B4-8B69-160EC7BBD8B1Q39456760-98A8119F-8E6D-46CA-8045-4C6EDFD31AD0Q40544175-2573389B-05B5-4B50-9643-0B99CE418E18Q53121086-3AF8B70F-9B50-4EFA-823B-7BED5E0780A9Q55139939-07AFB922-92A5-4A17-9411-C85E480D8C48
P2860
Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Postmenopausal hormone therapy ...... nterLymph case-control studies
@ast
Postmenopausal hormone therapy ...... nterLymph case-control studies
@en
type
label
Postmenopausal hormone therapy ...... nterLymph case-control studies
@ast
Postmenopausal hormone therapy ...... nterLymph case-control studies
@en
prefLabel
Postmenopausal hormone therapy ...... nterLymph case-control studies
@ast
Postmenopausal hormone therapy ...... nterLymph case-control studies
@en
P2093
P2860
P50
P356
P1433
P1476
Postmenopausal hormone therapy ...... nterLymph case-control studies
@en
P2093
InterLymph Consortium
J J Spinelli
L Bernstein
P M Bracci
P2860
P304
P356
10.1093/ANNONC/MDS340
P577
2012-09-11T00:00:00Z